Improving imaging techniques for small cell neuroendocrine prostate cancer
Co-Clinical Quantitative Imaging of Small Cell Neuroendocrine Prostate Cancer Using Hyperpolarized 13C MRI
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10908506
This study is testing a new imaging technique to help doctors see how well treatments are working for patients with small cell neuroendocrine prostate cancer, making it easier to track the effectiveness of therapies like carboplatin.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10908506 on ClinicalTrials.gov |
What this research studies
This research aims to enhance imaging methods for small cell neuroendocrine prostate cancer (SCNC) using advanced hyperpolarized 13C magnetic resonance imaging (MRI). By conducting preclinical studies alongside clinical trials, the project seeks to better assess how well treatments like carboplatin work for patients with metastatic SCNC. The innovative imaging techniques developed could provide more accurate insights into tumor response, which is crucial since traditional methods often fail to detect therapeutic efficacy. This approach addresses a significant gap in current cancer treatment monitoring, especially for tumors that are difficult to biopsy.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with metastatic small cell neuroendocrine prostate cancer who are undergoing treatment.
Not a fit: Patients with other types of prostate cancer or those not receiving treatment for metastatic small cell neuroendocrine prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring of treatment responses in patients with small cell neuroendocrine prostate cancer.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer monitoring, suggesting that this approach could yield valuable insights.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KURHANEWICZ, JOHN — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: KURHANEWICZ, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.